Latest filing published 12 Jul 2007 for BIOENVISION INC, €326k.
No signal scores available.
Thomas Scott Nelson appears in our data through filings on Bioenvision Inc shares, published by SEC (Form 4). Between 8 March 2006 and 10 July 2007, the trades on record add up to 3 filings.
Sales make up the whole of the open-market record (2 sales, €581k).
On 12 July 2007 came the latest disclosure, a transaction for €326k in Bioenvision Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations